{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-119934","form_type":"8-K","ticker":"CLB","cik":"0001958086","company_name":"Core Laboratories Inc. /DE/","filed_at":"2026-03-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.877510+00:00","generated_at":"2026-05-15T09:24:59.678952+00:00","sec_items":["7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Core Labs cuts Q1 2026 guidance citing Middle East conflict; revenue now $119-123M","bullets":["First quarter 2026 revenue guidance revised to $119M-$123M, down from previously issued guidance.","Operating income ex-items projected at $5.7M-$7.1M; EPS ex-items $0.05-$0.07.","Client-driven project delays, travel constraints, and supply-chain disruptions from Middle East conflict cited.","Reservoir Description segment most impacted; Production Enhancement less affected but energetics shipments delayed.","Earnings call scheduled for April 30, 2026; press release on April 29 after market close."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-119934","json":"https://secwatch.observer/filing/0001193125-26-119934.json","markdown":"https://secwatch.observer/filing/0001193125-26-119934.md","text":"https://secwatch.observer/filing/0001193125-26-119934.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958086/000119312526119934/0001193125-26-119934-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958086/000119312526119934/clb-20260323.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:24:59.678952+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}